Ken Griffin’s Intermolecular, Inc. IMI Stock Holding History

Ken Griffin’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-34,729	Closed	-$41K	–	10140
2019 Q2	$41K	Buy	+34,729	New	+$39.8K	﹤0.01%	8795
2018 Q2	–	Sell	-13,038	Closed	-$17K	–	9539
2018 Q1	$17K	Buy	+13,038	New	+$18.6K	﹤0.01%	8144
2017 Q2	–	Sell	-27,744	Closed	-$26K	–	8376
2017 Q1	$26K	Buy	+27,744	New	+$29K	﹤0.01%	7198
2016 Q3	–	Sell	-12,264	Closed	-$18K	–	8056
2016 Q2	$18K	Sell	12,264 -54	-0.4%	-$109	﹤0.01%	6657
2016 Q1	$31K	Buy	+12,318	New	+$27.8K	﹤0.01%	6372
2015 Q2	–	Sell	-14,513	Closed	-$24K	–	9280
2015 Q1	$24K	Buy	+14,513	New	+$24.7K	﹤0.01%	7805

Ken Griffin's IMI Position: Q3 2019 in Review

Ken Griffin sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 34,729 shares — an estimated $41K sold.

Ken Griffin first reported a position in IMI in Q1 2015 and held it in 6 quarters. The position peaked at $41K in Q2 2019. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.

Ken Griffin reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
Ken Griffin sold 34,729 Intermolecular, Inc. shares in Q3 2019, an estimated $41K.
Ken Griffin first reported a position in Intermolecular, Inc. in Q1 2015 and held it in 6 quarters.
Ken Griffin's Intermolecular, Inc. position peaked at $41K in Q2 2019.
0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.